ПРОГНОЗИРОВАНИЕ ТРАНСФОРМАЦИИ РЕЦИДИВИРУЮЩЕЙ ФОРМЫ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ В ХРОНИЧЕСКУЮ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ

ПРОГНОЗИРОВАНИЕ ТРАНСФОРМАЦИИ РЕЦИДИВИРУЮЩЕЙ ФОРМЫ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ В ХРОНИЧЕСКУЮ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ

To evaluate the prognostic significance of markers of fibrosis in the risk of transition persistent atrial fibrillation in chronic form. It was revealed that the performance of remodeling of the left atrium (the level of PICP, TIMP-1, and the index of the PL to the BSA) have predictive value in the...

Full description

Bibliographic Details
Main Authors:	Н. Е. Григориади, Л. М. Василец, А. В. Туев, А. В. Петруша, Е. А. Ратанова
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2014-04-01
Series:	Архивъ внутренней медицины
Subjects:	atrial fibrillation arterial hypertension cardiac fibrosis matrix metalloproteinase-9 tissue inhibitor of metalloproteinase-1 c-terminal propeptide of procollagen type i prediction
Online Access:	https://www.medarhive.ru/jour/article/view/277

Similar Items

Serum Concentrations of Matrix Metalloproteinase‐1 and Procollagen Type I Carboxy Terminal Propeptide Discriminate Infarct‐Like Myocarditis and Non−ST‐Segment−Elevation Myocardial Infarction
by: Lucas Bacmeister, et al.
Published: (2024-07-01)

Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy
by: Patrício Aguiar, et al.
Published: (2018-03-01)

ВСЯ ПРАВДА О ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
by: А. Л. Вёрткин, et al.
Published: (2013-08-01)

СТРАТИФИКАЦИЯ РИСКА ПРОГРЕССИРОВАНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
by: В. А. Снежицкий, et al.
Published: (2023-11-01)

<i>Actinidia chinensis</i> Planch Ameliorates Photoaging in UVB-Irradiated NIH-3T3 Cells and SKH-1 Hairless Mice by Controlling the Reactive Oxygen Species/AKT Pathway
by: Jong-Min Jung, et al.
Published: (2024-09-01)

Lentinula edodes extract inhibits matrix metalloproteinase expression and increases type I procollagen expression via the p38 MAPK/c-Fos signaling pathway in ultraviolet A and B-irradiated HaCaT keratinocytes
by: Jung Im Lee, et al.
Published: (2021-01-01)

АДЕКВАТНОСТЬ АНТИТРОМБОТИЧЕСКОЙ ТЕРАПИИ ПРИ НЕКЛАПАННОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ В РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ
by: Е. И. Баранова, et al.
Published: (2015-07-01)

The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)

Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients
by: Carina Ureche, et al.
Published: (2023-02-01)

The Mechanism and Role of ADAMTS Protein Family in Osteoarthritis
by: Ting Li, et al.
Published: (2022-07-01)

Влияние стимуляции спинного мозга на хроническую модель фибрилляции предсердий в эксперименте на мини-свиньях
by: V.V. Shabanov, et al.
Published: (2023-12-01)

Serum level of N-terminal propeptide of type I procollagen in people of various ages and gender
by: V.V. Povoroznyuk, et al.
Published: (2020-02-01)

The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
by: Elma Kučukalić-Selimović, et al.
Published: (2013-11-01)

ПРИМЕНЕНИЕ ПЕРОРАЛЬНЫХ АНТИКОАГУЛЯНТОВ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ И НОВЫЕ ВОЗМОЖНОСТИ
by: Г. И. Сторожаков, et al.
Published: (2013-04-01)

Bone turnover markers and bone mineral density in prepubertal obese children
by: Ola Taha, et al.
Published: (2024-11-01)

Новая эндокардиальная би-электродная стимуляция правого предсердия у мини-свиней для создания модели фибрилляции предсердий
by: Д.В. Лосик, et al.
Published: (2023-03-01)

Когнитивные нарушения у пациентов с фибрилляцией предсердий и артериальной гипертонией
by: А. Ковалева, et al.
Published: (2022-03-01)

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases
by: Monika Gudowska, et al.
Published: (2017-09-01)

Динамика клинико-функционального состояния пациентов с ишемической болезнью сердца после хирургического лечения фибрилляции предсердий
by: А. М. Чернявский, et al.
Published: (2015-10-01)

Радиочастотная изоляция устьев легочных вен для профилактики вновь возникшей фибрилляции предсердий после аортокоронарного шунтирования
by: А. Ревишвили, et al.
Published: (2020-09-01)

ВЛИЯНИЕ АНТАГОНИСТОВ АЛЬДОСТЕРОНА НА ПАРАМЕТРЫ ЭЛЕКТРОКАРДИОГРАММЫ ВЫСОКОГО РАЗРЕШЕНИЯ У ПАЦИЕНТОВ С ПАРОКСИЗМАЛЬНОЙ ФОРМОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
by: Н. Т. Ватутин, et al.
Published: (2015-08-01)

Inflammation and Fibrosis in Sleep-Disordered Breathing after Acute Myocardial Infarction
by: Jan Pec, et al.
Published: (2024-01-01)

СТРАТИФИКАЦИЯ РИСКА ПРОГРЕССИРОВАНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ И ВОЗМОЖНОСТИ ВТОРИЧНОЙ ПРОФИЛАКТИКИ
by: Н. В. Буквальная, et al.
Published: (2023-05-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Предикторы развития фибрилляции предсердий в раннем послеоперационном периоде после операций на открытом сердце
by: О. Бруева, et al.
Published: (2021-09-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

The relationship between the first episode of wheezing and matrix metalloproteinases-9 and MMP-2 and tissue inhibitors of MMP-1 levels in preterm infants
by: Rabia Gonul Sezer, et al.
Published: (2013-01-01)

ОТДАЛЕННЫЕ РЕЗУЛЬТАТЫ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ У БОЛЬНЫХ С ПРИОБРЕТЕННЫМИ ПОРОКАМИ МИТРАЛЬНОГО КЛАПАНА
by: С. И. Железнев, et al.
Published: (2015-10-01)

N-TERMINAL PROPEPTIDE OF COLLAGEN TYPE III AS A PROPOSED MARKER OF MYOCARDIAL FIBROSIS IN TYPE 2 DIABETES
by: O. M. Drapkina, et al.
Published: (2018-06-01)

Intra-Individual Changes in Total Procollagen-Type 1 N-terminal Propeptide in a Korean Adult Population
by: Rihwa Choi, et al.
Published: (2022-10-01)

Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
by: Mitsuru Furukawa, et al.
Published: (2022-09-01)

Investigation of multinucleation and apoptosis of macrophages of BCG-infected mice and their production of cathepsins and matrix metalloproteinases
by: D. А. Il’in
Published: (2024-04-01)

Association between blood procollagen III N-terminal propeptide, granulocyte-macrophage colony-stimulating factor and triple therapy in single inhaler efficacy for chronic obstructive pulmonary disease re-exacerbation prevention
by: L. A. Shpagina, et al.
Published: (2024-04-01)

Proteolysis/antiproteolysis system in apparently healthy men and women of different ages
by: Vladimir N. Yushchuk, et al.
Published: (2024-09-01)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

ПРОФИЛАКТИКА ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ У ПАЦИЕНТОВ С ТРЕПЕТАНИЕМ ПРЕДСЕРДИЙ
Published: (2019-06-01)

Expression of MMP-2, MMP-9 and TIMP-2 in pituitary tumors and their relationship with cavernous sinus invasion
by: Ane Caroline Thé B Freire, et al.
Published: (2025-01-01)